News

Compound blocks SARS-CoV-2 and protects lung cells, study finds

Compound blocks SARS-CoV-2 and protects lung cells, study finds
Science
Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that Elovanoids, bioactive chemical messengers made from omega-3 very-long-chain polyunsaturated fatty acids discovered by the Bazan lab in 2017, may block the virus that causes COVID-19 from entering cells and protect the air cells (alveoli) of the lung. Their findings are published online in Scientific Reports.

advertisement

"Because the compounds are protective against damage in the brain and retina of the eye and the COVID-19 virus clearly damages the lung, the experiment tested if the compounds would also protect the lung," notes Nicolas Bazan, MD, PhD, Director of the LSU Health New Orleans Neuroscience Center and senior author of the paper.

The research team tested Elovanoids (ELVs) on infected lung tissue from a 78-year-old man in petri dish cultures. They found that ELVs not only reduced the ability of the SARS-CoV-2 spike protein to bind to receptors and enter cells, but they also triggered the production of protective, anti-inflammatory proteins that counteract lung damage.

The scientists report that ELVs decreased the production of ACE2. ACE2 is a protein on the surface of many cell types. ACE2 receptors act like locks on cells, and the SARS-CoV-2 spike proteins act like keys that open the locks letting the virus enter cells to multiply rapidly. They also demonstrated for the first time that alveolar cells are endowed with pathways for the biosynthesis of ELVs.

"Since SARS-CoV-2 affects nasal mucosa, the GI tract, the eye, and the nervous system, uncovering the protective potential of ELVs expands the scope of our observations beyond the lung," adds Dr. Bazan. "Our results provide a foundation for interventions to modify disease risk, progression, and protection of the lung from COVID-19 or other pathologies (including some types of pneumonia)."

The LSU Health New Orleans research team included Drs. Jorgelina M. Calandria, Surjyadipta Bhattacharjee, Marie-Audrey I. Kautzmann, Aram Asatryan, William C. Gordon, Khanh V. Do, Bokkyoo Jun, and Pranab K. Mukherjee, as well as Dr. Nicholas J. Maness from Tulane University and Dr. Nicos A. Petasis from the University of Southern California.

This work was supported by an Institutional Grant from the LSU Health New Orleans School of Medicine.

Materials provided by . Note: Content may be edited for style and length.

Louisiana State University Health Sciences Center. "Compound blocks SARS-CoV-2 and protects lung cells, study finds." ScienceDaily. ScienceDaily, 10 June 2021. .

Louisiana State University Health Sciences Center. "Compound blocks SARS-CoV-2 and protects lung cells, study finds." ScienceDaily. www.sciencedaily.com/releases/2021/06/210610135529.htm (accessed June 10, 2021).

advertisement

1

Nov. 15, 2018 — A new review has found that increasing the intake of omega-3 long-chain polyunsaturated fatty acids (LCPUFA) during pregnancy reduces the risk of premature ...

Mar. 19, 2018 — Could omega-6 fatty acids protect you against premature death? The answer is yes, according to a new study. While protecting against death, omega-6 fatty acids also keep cardiovascular diseases at ...

Sep. 27, 2017 — Scientists have discovered a new class of molecules in the brain that synchronize cell-to-cell communication and neuroinflammation/immune activity in response to injury or diseases. Elovanoids (ELVs) ...

May 18, 2017 — Two new studies link patterns of polyunsaturated fatty acids in the blood to the integrity of brain structures and cognitive abilities that are known to decline early in aging. The studies add to the ...
Read more on sciencedaily.com
News Topics :
RELATED STORIES :
Science
A study of a gateway receptor for SARS CoV 2 led by Walter Lukiw, PhD, Professor of Neuroscience, Neurology and Ophthalmology at LSU Health New Orleans Neuroscience Center of Excellence and...
Science
Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that a combination of an LSU Health patented drug and selected DHA derivatives is more effective in protecting brain...
Science
Research led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, and Ludmila Belayev, MD, LSU...
Science
Close A team of researchers led by Nicolas Bazan, MD, PhD, Boyd Professor and Director of the Neuroscience Center of Excellence at LSU Health New Orleans School of Medicine, has...
Science
James Diaz, MD, MHA, MPH & TM, Dr PH, Professor and Head of Environmental Health Sciences at LSU Health New Orleans School of Public Health, has proposed a possible explanation...